Company research

Rhythm Pharmaceuticals Inc

RYTM

Current Tracked Holder
1
One-Year Insider Activity
Purchases 0 $0
Sales 55 $41.7M

Price history

Price history loads when this section approaches view.

Quarter-End Change Analysis

No published quarterly analysis yet

Reviewed research will appear here when it is published.

Current reported holders

Portfolio ManagerRecent activitySharesValuePortfolio
Stanley DruckenmillerDuquesne Family Office LLC
RYTMNew
203,618
$22,608,000
0.43%

Long-term company research

Fundamental analysis

Research pending

Fundamental research pending

Reviewed company research will appear here when available.

Financial data loads when this section approaches view.

Insider activity

1-year insider activity

Open-market purchases and sales only.

Checked 2026-10-02
DateInsiderTypeSharesPriceValueSource
2026-09-14Meeker David PDirector, President and CEOSale6,439$102$655,145SEC ↗
2026-09-14Meeker David PDirector, President and CEOSale30,746$102$3.1MSEC ↗
2026-09-14Meeker David PDirector, President and CEOSale8,698$103$899,634SEC ↗
2026-09-14Meeker David PDirector, President and CEOSale1,817$105$189,965SEC ↗
2026-09-14Meeker David PDirector, President and CEOSale2,300$105$241,937SEC ↗
2026-08-31Smith Hunter CChief Financial OfficerSale23,072$105$2.4MSEC ↗
2026-08-31Smith Hunter CChief Financial OfficerSale11,514$105$1.2MSEC ↗
2026-08-31Smith Hunter CChief Financial OfficerSale28,188$106$3.0MSEC ↗
2026-08-13Shulman JosephChief Technical OfficerSale5,079$120$608,210SEC ↗
2026-08-13Garfield AlastairChief Scientific OfficerSale2,007$116$233,031SEC ↗